Cargando…
Anti-Triggering Receptor Expressed on Myeloid Cells-Like Transcript-1 Antibodies in Systemic Lupus Erythematosus
Autores principales: | Vilá, Luis M., Nieves-Plaza, Mariely, Vales Torres, Xariana, Nieves, Benjamín, Valance Washington, A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Mesut Onat
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10544204/ https://www.ncbi.nlm.nih.gov/pubmed/37249307 http://dx.doi.org/10.5152/eurjrheum.2023.22051 |
Ejemplares similares
-
Association of soluble TREM-like transcript-1 with clinical features and patient reported outcomes in systemic lupus erythematosus
por: Vázquez-Otero, Ileana, et al.
Publicado: (2018) -
Patient-reported outcome measures in a population of medically indigent patients with systemic lupus erythematosus in Puerto Rico
por: Rodríguez-Rivera, Diana V, et al.
Publicado: (2016) -
The Characterization and Evaluation of the Soluble Triggering Receptor Expressed on Myeloid Cells-like Transcript-1 in Stable Coronary Artery Disease
por: Bayrón-Marrero, Zaida, et al.
Publicado: (2023) -
High Levels of Soluble Triggering Receptor Expressed on Myeloid Cells–Like Transcript (TLT)-1 Are Associated With Acute Respiratory Distress Syndrome
por: Morales-Ortíz, Jessica, et al.
Publicado: (2018) -
Rapid aneurysm growth and rupture in systemic lupus erythematosus
por: Graffeo, Christopher S., et al.
Publicado: (2015)